Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

135.01
Delayed Data
As of 4:00pm ET
 -0.47 / -0.35%
Today’s Change
127.10
Today|||52-Week Range
242.37
-29.66%
Year-to-Date
Weekly CEO Sells Highlights
6:37pm / GuruFocus News - Paid Partner Content
Genomic Health Brings Liquid Biopsy Test for Stage IV Cancer
Jun 17 / Zacks.com - Paid Partner Content
Jim Cramer's Top Takeaways: Polaris, Thor, Danaher
Jun 22 / TheStreet.com - Paid Partner Content
President raises patient and business hope for cancer treatment
Jun 02 / FT.com - Paid Partner Content

Today’s Trading

Previous close135.48
Today’s open136.41
Day’s range133.58 - 138.90
Volume1,168,375
Average volume (3 months)1,368,424
Market cap$19.9B
Dividend yield--
Data as of 4:00pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)+30.80%
Earnings growth (this year)+1.80%
Earnings growth (next 5 years)+13.75%
Revenue growth (last year)+19.25%
P/E ratio48.5
Price/Sales12.89
Price/Book10.74

Competitors

 Today’s
change
Today’s
% change
AAgilent Technologies...+0.85+2.01%
WATWaters Corp+1.49+1.12%
MTDMettler-Toledo Inter...+8.98+2.58%
PKIPerkinElmer Inc+0.42+0.83%
Data as of 4:11pm ET, 06/28/2016

Financials

Next reporting dateJuly 19, 2016
EPS forecast (this quarter)$0.73
Annual revenue (last year)$2.2B
Annual profit (last year)$461.6M
Net profit margin20.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jay T. Flatley
President &
Director
Francis A. deSouza
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs